Ronald E. Bruehlman
Net Worth

Last updated: 4 Aug 2020

What is Ronald E. Bruehlman net worth?

The estimated net worth of Mr. Ronald E. Bruehlman is at least $13,471,211 as of 4 Aug 2020. He owns shares worth $5,121,211 as insider and has received compensation worth at least $8,350,000 in IQVIA Holdings Inc..

What is the salary of Ronald E. Bruehlman?

Mr. Ronald E. Bruehlman salary is $1,670,000 per year as Executive Vice President & Chief Financial Officer in IQVIA Holdings Inc..

How old is Ronald E. Bruehlman?

Mr. Ronald E. Bruehlman is 64 years old, born in 1961.

What stocks does Ronald E. Bruehlman currently own?

As insider, Mr. Ronald E. Bruehlman owns shares in one company:

Company	Title	Shares	Price per share	Total value
IQVIA Holdings Inc. (IQV)	Executive Vice President & Chief Financial Officer	26,751	$191.44	$5,121,211

What does IQVIA Holdings Inc. do?

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.